The First Crispr Medicine Is Now Approved in the US
The one-time gene editing fix is meant to halt debilitating pain crises for sickle cell patients, who formerly could only be cured with a risky stem cell transplant.
The one-time gene editing fix is meant to halt debilitating pain crises for sickle cell patients, who formerly could only be cured with a risky stem cell transplant.